JPMorgan Chase & Co. Raises Holdings in Maximus, Inc. (NYSE:MMS)

JPMorgan Chase & Co. lifted its holdings in Maximus, Inc. (NYSE:MMS - Free Report) by 46.0% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 326,748 shares of the health services provider's stock after buying an additional 102,982 shares during the period. JPMorgan Chase & Co. owned approximately 0.57% of Maximus worth $24,392,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the business. Vanguard Group Inc. lifted its stake in Maximus by 3.2% in the 4th quarter. Vanguard Group Inc. now owns 6,548,284 shares of the health services provider's stock worth $488,829,000 after purchasing an additional 205,564 shares in the last quarter. Geode Capital Management LLC increased its holdings in shares of Maximus by 1.4% in the third quarter. Geode Capital Management LLC now owns 1,525,159 shares of the health services provider's stock valued at $142,109,000 after purchasing an additional 21,532 shares during the last quarter. Van Berkom & Associates Inc. lifted its position in Maximus by 8.5% during the fourth quarter. Van Berkom & Associates Inc. now owns 1,256,418 shares of the health services provider's stock worth $93,792,000 after buying an additional 98,264 shares in the last quarter. Charles Schwab Investment Management Inc. boosted its stake in Maximus by 7.7% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 1,000,664 shares of the health services provider's stock worth $74,700,000 after buying an additional 71,598 shares during the last quarter. Finally, Allspring Global Investments Holdings LLC grew its holdings in Maximus by 2.4% in the 4th quarter. Allspring Global Investments Holdings LLC now owns 722,172 shares of the health services provider's stock valued at $54,748,000 after buying an additional 16,772 shares in the last quarter. 97.21% of the stock is currently owned by institutional investors and hedge funds.

Remove Ads

Maximus Trading Down 0.8 %

MMS stock traded down $0.53 during midday trading on Tuesday, hitting $68.21. 19,523 shares of the company's stock were exchanged, compared to its average volume of 680,686. Maximus, Inc. has a 1-year low of $63.77 and a 1-year high of $93.97. The business has a 50-day simple moving average of $67.75 and a two-hundred day simple moving average of $75.87. The stock has a market capitalization of $3.86 billion, a PE ratio of 14.66 and a beta of 0.68. The company has a current ratio of 1.72, a quick ratio of 1.72 and a debt-to-equity ratio of 0.82.

Maximus (NYSE:MMS - Get Free Report) last issued its quarterly earnings data on Thursday, February 6th. The health services provider reported $1.61 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.39 by $0.22. Maximus had a net margin of 5.28% and a return on equity of 21.95%. On average, sell-side analysts predict that Maximus, Inc. will post 6.15 EPS for the current fiscal year.

Maximus Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Saturday, May 31st. Investors of record on Thursday, May 15th will be issued a $0.30 dividend. The ex-dividend date of this dividend is Thursday, May 15th. This represents a $1.20 annualized dividend and a yield of 1.76%. Maximus's dividend payout ratio (DPR) is presently 25.81%.

Insider Buying and Selling at Maximus

In other news, Director Jan Madsen sold 2,439 shares of the stock in a transaction dated Tuesday, March 18th. The shares were sold at an average price of $67.71, for a total transaction of $165,144.69. Following the sale, the director now owns 18,097 shares of the company's stock, valued at approximately $1,225,347.87. This represents a 11.88 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Ilene R. Baylinson sold 14,500 shares of Maximus stock in a transaction that occurred on Wednesday, February 19th. The shares were sold at an average price of $68.14, for a total transaction of $988,030.00. Following the completion of the transaction, the insider now owns 2,512 shares of the company's stock, valued at $171,167.68. This trade represents a 85.23 % decrease in their position. The disclosure for this sale can be found here. 1.60% of the stock is owned by corporate insiders.

Analyst Ratings Changes

MMS has been the topic of several analyst reports. Raymond James upgraded Maximus from a "market perform" rating to an "outperform" rating and set a $90.00 price target on the stock in a report on Thursday, January 2nd. StockNews.com cut shares of Maximus from a "buy" rating to a "hold" rating in a research note on Friday, February 14th.

Maximus Company Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.